Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Invested Capital (2024 - 2025)

Updated

Adaptimmune Therapeutics (ADAPY) posted Invested Capital of -$45.33 million for Q2 2025, compared with $121.23 million a year earlier.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Invested Capital (2024 - 2025) Analysis & Trends

For FY2024, Adaptimmune Therapeutics' Invested Capital came in at $62.09 million.

  • According to Business Quant data, Invested Capital for the three prior quarters was -$12.02 million (Q1 2025), $62.09 million (Q4 2024) and $129.85 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -45.33 Mn
Mar 31, 2025 -12.02 Mn
Dec 31, 2024 62.09 Mn
Sep 30, 2024 129.85 Mn
Jun 30, 2024 121.23 Mn
API Access

Adaptimmune Therapeutics PLC Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ADAPY&period=max&api_key=YOUR_API_KEY